P300 event related potential application to cognitive status assessment of the patients with subclinical hypothyroidism

M. Dejanovic ,
M. Dejanovic
V. Ivetic ,
V. Ivetic
V. Nestorovic ,
V. Nestorovic
Z. Milanovic ,
Z. Milanovic
B. Bisevac ,
B. Bisevac
M. Miletic ,
M. Miletic
M. Miric
M. Miric

Published: 01.06.2015.

Volume 44, Issue 2 (2015)

pp. 97-102;

https://doi.org/10.5937/pramed1502097d

Abstract

Disturbances of thyroid function are often accompanied by cognitive and affective disorders. Assessment of cognitive status in the patients with subclinical hypothyroidism represents a possibility for early diagnostics of cognitive impairment and timely introduction of necessary pharmacotherapy treatment. The aim of this study was to quantify whether there are P3 event related potential (ERP) deviations as electrophysiological markers of cognitive activity in patients with subclinical hypothyroidism. P300 potentials were examined in thirty patients with subclinical hypothyroidism and in 30 healthy subjects of the control group. P300 was recorded using the classic auditory oddball paradigm, with 20% of target and 80% of non-target stimuli. The results analysis showed a significantly longer latency P300 and reduced amplitude P300 in subjects with subclinical hypothyroidism compared to euthyroid subjects. There is also a statistically significant negative correlation between the results of a mini mental state examination and the P300 latency at Fz electrode (r= -0.47, p <0.01) and Cz electrode (r= -0.43, p =0.017). P300 ERP is important in the evaluation of patients with subclinical hypothyroidism, due to the sensitivity in the detection cognitive disorders.

Keywords

References

1.
Davis J, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinologica. 2007;49–65.
2.
Bernal J. Action of thyroid hormone in brain. Journal of Endocrinological Investigation. 2002;268–88.
3.
Owen P, Lazarus J. Subclinical hypothyroidism:the case for treatment. Trends Endocrinol Metab. 2003;257–61.
4.
Monzani F, Dardano A, Caraccio N. Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol. 2006;65–81.
5.
Gharib H, Tuttle M, Baskin J, Fish L, Singer P, Mcdermott M. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab. 2005;(1):586–7.
6.
Volpato S, Guralnik J, Fried L, Remaley A, Cappola A, Launer L. Serum thyroxine level and cognitive decline in euthyroid older women. Neurology. 2002;(7):1055–61.
7.
Samuels M, Schuff K, Carlson N, Carello P, Anowsky J. Health status, psychological symptoms, mood, and cognition in lthyroxine-treated hypothyroid subjects. Thyroid. 2007;249–58.
8.
Bird T, Miller B, Kasper D, Braunwald E, Hauser S, Longo D, et al. Harrison’s Principles of Internal Medicine. 2005;2397.
9.
Jorde R, Waterloo K, Storhaug H, Nyrnes A, Sundsfjord J, Jenssen T. Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment. J Clin Endocrinol Metab. 2006;(1):145–53.
10.
Roberts L, Pattison H, Roalfe A. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med. 2006;(8):573–81.
11.
Surks M, Ortiz E, Daniels G, Sawin C, Col N, Cobin R, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;228–38.
12.
Helfand M. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Int Med. 2004;128–41.
13.
Wekking E, Appelhof B, Fliers E. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;(6):747–53.
14.
Folstein M, Folstein S, Mchugh P. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;(3):189–98.
15.
Polich J, Herbst K. P300 as a clinical assay: rationale, evaluation, and findings. Int J Psychophysiol. 2000;3–19.
16.
2014;
17.
Yamaguchi S, Knight R. P300 generation by novel somatosensory stimuli. Electroencephalogr Clin Neurophysiol. 1991;50–5.
18.
Bennys K, Portet F, Touchon J, Rondouin G. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer’s disease and mild cognitive impairment. J Clin Neurophysiol. 2007;405–12.
19.
Golob E, Irimajiri R, Starr A. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia. Brain. 2007;740–52.
20.
Frodl T, Hampel H, Juckel G, Bürger K, Padberg F, Engel R, et al. Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer’s Disease. Psychophysiology. 2002;75–181.
21.
Golob E, Johnson J, Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin Neurophysiol. 2002;151–61.
22.
Irimajiri R, Golob E, Starr A. Auditory brain-stem, middle-and long-latency evoked potentials in mild cognitive impairment. Clin Neurophysiol. 2005;1918–29.
23.
Polich J. P300 in clinical applications. 1999;1073–91.
24.
Jensovsky J, Ruzicka E, Spackova N, Hejdukova B. Changes of event related potentials and cognitive processes in patients with subclinical hypotiroidism after thyroxine treatment. Endocrine Regulations. 2002;122–55.
25.
Munte T, Lill C, Otting G, Brabant G. Cognitive changes in short-term hypothyroidism assessed with event-related brain potentials. Psychoneuroendocrinology. 2004;(9):1109–18.
26.
Hansenne M. The p300 cognitive event-related potential. II. Individual variability and clinical application in psychopathology. Neurophysiol Clin. 2000;211–31.
27.
Bocquillon P, Dujardin K, Betrouni N, Phalempin V, Houdayer E, Bourriez J, et al. Attention impairment in temporal lobe epilepsy: a neurophysiological approach via analysis of the P300 wave. Hum Brain Mapp. 2009;(7):2267–77.
28.
Chiappa K. Principles of evoked potentials. 1990;(2):1–36.
29.
Zhu D, Wang Z, Zhang D, Pan Z, He S, Hu X, et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain. 2006;2923–30.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by